Bioanalytical Sensors

Share:

EmailFacebookLinkedInXWhatsAppShare
Bioanalytical Sensors program supports the development of sensor technologies for the detection and quantitation of clinically relevant analytes in complex matrices for use in biomedical applications.

Emphasis

Emphasis is on engineering the components and functionality of bioanalytical sensors. Detection could be based on optical, chemical, electrochemical, and/or physical (such as mechanical, gravimetric, thermal) perturbation of a sample, for example. Examples of technologies of interest include, but are not limited to:

  • nano-textured substrates for analyte detection
  • DNA sensors for liquid biopsy
  • small molecule detectors for diagnosing infectious diseases.

Notes

The development of biomedical devices that use bioanalytical sensors is supported by the NIBIB Point of Care Technologies program. The development of imaging probes is supported by the NIBIB Molecular Probes and Imaging Agents program. 

    Related News

    June 29, 2022
    3D rendering of SARS-CoV-2
    Researchers funded by NIH's RADx Tech program have developed a fast, cost-effective method to detect the circulation of SARS-CoV-2 variants. The team adopted a customizable genotyping approach to identify known variants and subvariants—an approach that can augment current surveillance.
    October 19, 2020
    Thin tissue grafts and flexible electronics have a host of applications for wound healing, regenerative medicine and biosensing. A new device inspired by an octopus's sucker rapidly transfers delicate tissue or electronic sheets to the patient, overcoming a key barrier to clinical application.
    July 22, 2020
    covid-19 rendering
    In a paper in the New England Journal of Medicine, scientific leaders from the National Institutes of Health set forth a framework to increase significantly the number, quality and type of daily tests for detecting SARS-CoV-2, the virus that causes COVID-19, and help reduce inequities for underserved populations that have been disproportionally affected by the disease.